AMENDMENT NO. 2 TO COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT
AMENDMENT NO. 2
TO COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT
This Amendment No. 2 to the Collaboration and Exclusive License Agreement (this “Amendment”) effective as of February 29, 2016 (the “Amendment Date”), is entered into is made by and between (i) AnaptysBio, Inc., a Delaware corporation, having a place of business at 00000 Xxxxxxx Xxxxxx Xxxxx, Xxxxx 000, Xxx Xxxxx, Xxxxxxxxxx 00000 (“AnaptysBio”), and (ii) TESARO, Inc., a Delaware corporation, having a place of business at 0000 Xxxxxx Xxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxxxxxxxxxx 00000 (“TESARO US”) and TESARO Development, Ltd., a Bermuda corporation, having its principal office at Xxxxxxxxx Xxxxx, 0 Xxxxxx Xxxxxx, Xxxxxxxx XX 00, Bermuda (together with TESARO US, “TESARO”).
WHEREAS, the parties previously entered into that certain Collaboration and Exclusive License Agreement dated as of March 10, 2014 (the “Agreement”);
WHEREAS, the parties wish to amend the Agreement in certain respects on the terms and conditions set forth herein.
NOW THEREFORE, capitalized terms not defined in this Amendment shall have the meaning ascribed in the Agreement, and the parties hereby agree as follows:
Section 2.7 of the Agreement is hereby amended and replaced in its entirety as follows:
2.7.Term of Discovery Program. Each Discovery Program Term shall commence on the Effective Date and shall end upon the earlier of (i) December 31st 2016, or such other date as the Parties may agree through the JSC, (ii) a decision by TESARO to discontinue funding of all activities under such Discovery Program, or (iii) a mutual decision by TESARO and AnaptysBio to cease activities with respect to that Discovery Program.
This Amendment shall be effective for all purposes as of the Amendment Date. Except as expressly modified herein, the Agreement shall continue to remain in full force and effect in accordance with its terms. This Amendment may be executed in counterparts, each of which shall be deemed to be an original and together shall be deemed to be one and the same document.
IN WITNESS WHEREOF, the parties have caused this Amendment to be executed by their respective duly authorized representatives effective as of the Amendment Date.
|
|
ANAPTYSBIO, Inc. |
|
|
|
|
|
|
By: /s/ Xxxx Xxxxx Xxxxxx |
|
By: /s/ Xxxxx Xxxxx |
|
|
|
|
|
Name: Xxxx Xxxxx Xxxxxx |
|
Name: Xxxxx Xxxxx |
|
|
|
|
|
Title: President and Chief Operating Officer |
|
Title: President & CEO |
|
|
|
|
|
|
|
|
|
|
|
|
|
TESARO DEVELOPMENT, LTD. |
|
|
|
|
|
|
|
By: /s/ Xxxxxx Xxxxxx |
|
|
|
|
|
|
|
Name: Xxxxxx Xxxxxx |
|
|
|
|
|
|
|
Title: Director/Vice President |
|
|
